Geistlich acquires Bionnovation Biomedical
Wolhusen/Bauru - Geistlich Pharma has completed a takeover of the Brazilian medtech firm Bionnovation Biomedical. With this acquisition, Geistlich is seeking to expand its portfolio in the field of dental implants.
Geistlich Pharma, a specialist in the regeneration of bones, cartilage and tissue, has acquired the Brazilian medtech firm Bionnovation Biomedical. With this acquisition, Geistlich is seeking to expand its portfolio in the field of dental care and dental implants, further details of which can be found in a press release. Bionnovation Biomedical sells its products in more than 20 countries and has experienced sharp growth over the past few years. With the acquisition now having been finalized, Geistlich intends to offer dentists and patients improved access to regenerative dentistry products at affordable prices, as the company writes in the press release. Moreover, the company is aiming to offer reliable treatment solutions in Latin America and other emerging markets.
«We are excited to be able to offer our clinicians in future an even wider range of trustworthy solutions to fulfill the medical needs of their patients», comments Diego Gabathuler, CEO of Geistlich, in the press release.
Geistlich Pharma is headquartered in Wolhusen in the canton of Lucerne and forms part of the Geistlich Group from Schlieren in the canton of Zurich.
